Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells.

Galetto, Alessandra; Buttiglieri, Stefano; Forno, Sarah; Moro, Francesco; Mussa, Antonio; Matera, Lina

Galetto, Alessandra; Buttiglieri, Stefano; Forno, Sarah; Moro, Francesco; Mussa, Antonio; Matera, Lina.

Affiliation

Galetto A; Department of Oncology, Centro OncoEmatologicoSubalpino (COES), University of Turin, Italy.

Anticancer Drugs ; 14(10): 833-43, 2003 Nov.

Article in En | MEDLINE | ID: mdl-14597879

Subject(s)

Antigens, Neoplasm/immunology; Antimetabolites, Antineoplastic/pharmacology; Dendritic Cells/immunology; Killer Cells, Lymphokine-Activated/immunology; Myeloid Cells/immunology; Antigen Presentation/drug effects; Antigen Presentation/immunology; Antigen Presentation/radiation effects; Apoptosis/immunology; Cell Line, Tumor; Cytotoxicity, Immunologic; Fluorouracil/pharmacology; Gamma Rays; Histocompatibility Antigens Class I/immunology; Humans; T-Lymphocytes, Cytotoxic/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Dendritic Cells / Killer Cells, Lymphokine-Activated / Myeloid Cells / Antigens, Neoplasm / Antimetabolites, Antineoplastic Limits: Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2003 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links